James Levine, CEO of Verenium Corp., “Eco-Friendly Enzyme Products for Today’s Global Industries”

On May 9, 2013 By

James Manuso, Ph.D., Chairman & CEO of Astex Pharmaceuticals, “Small Molecule Therapeutics with Focus on Oncology & Hematology”

On May 8, 2013 By

Karl Forssman, COO of Incintas Therapeutics, “Focused on Improving Fertility Success by Encouraging Single Embryo Transfer”

On April 25, 2013 By

Tommy Cunningham, Ph.D. from CCB Research Group, “NFANT: Neonatal Feeding Assessment for Nutritional Transition”

On April 24, 2013 By

Dave Bjerken, CEO of InTailor Surgical, LLC., “Transoral Bariatric Technologies: Bariatric Surgery for Weight Loss”

On April 24, 2013 By

Peggy Sammon, CEO of GeneCapture, “Developing Product for Rapid Infection Detection Using Genetic Signatures”

On April 24, 2013 By

Stan Yakatan, CEO of TheraKine Ltd., “Drug Delivery Technology for Sustained Release of Biologics”

On April 17, 2013 By

Carles Domenech, Ph.D., CEO & Co-Founder of Ability Pharmaceuticals, “Developing New Drug Class of Anti-Cancer Compounds: Lipid Analogue Therapeutics”

On April 15, 2013 By

Dr. Andreas Voigt, Chief Scientist TheraKine Ltd., “Drug Delivery Technology for Biologics and Small Molecules”

On March 20, 2013 By

Barbara Grenell, Principal at Preferred Health Strategies, Ltd., “How Private Insurance Sector Looks at New Medical Devices”

On March 13, 2013 By